{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T15:45:38Z","timestamp":1763480738524,"version":"build-2065373602"},"reference-count":23,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.urolonc.2024.01.004","type":"journal-article","created":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T16:06:52Z","timestamp":1705594012000},"page":"72.e1-72.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Simplified cardiovascular index may be the best comorbidity index for clinical use in prediction of mortality for renal cancer patients"],"prefix":"10.1016","volume":"42","author":[{"given":"Dennis","family":"Boynton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina L.","family":"Noyes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adharsh","family":"Murali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry","family":"Peabody","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Krumm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karandeep","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1084-1519","authenticated-orcid":false,"given":"Brian R.","family":"Lane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2024.01.004_bib0001","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1093\/jnci\/djj362","article-title":"Rising incidence of small renal masses: a need to reassess treatment effect","volume":"98","author":"Hollingsworth","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.urolonc.2024.01.004_bib0002","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/MLR.0000000000000657","article-title":"Understanding treatment disconnect and mortality trends in renal cell carcinoma using tumor registry data","volume":"55","author":"Smaldone","year":"2017","journal-title":"Med Care"},{"key":"10.1016\/j.urolonc.2024.01.004_bib0003","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/JU.0000000000001911","article-title":"Renal mass and localized renal cancer: evaluation, management, and follow-up: AUA guideline: part I","volume":"206","author":"Campbell","year":"2021","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.urolonc.2024.01.004_bib0004","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.euo.2023.01.008","article-title":"A matched analysis of active surveillance versus nephrectomy for T1a small renal masses","volume":"6","author":"Cheung","year":"2023","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.urolonc.2024.01.004_bib0005","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1002\/cncr.25184","article-title":"Active treatment of localized renal tumors may not impact overall survival in patients aged 75 years or older","volume":"116","author":"Lane","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2024.01.004_bib0006","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.juro.2016.03.133","article-title":"Life expectancy and variation in treatment for early stage kidney cancer","volume":"196","author":"Daskivich","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2024.01.004_bib0007","doi-asserted-by":"crossref","first-page":"44","DOI":"10.6004\/jnccn.2019.7350","article-title":"Conditional survival of patients with nonmetastatic renal cell carcinoma: how cancer-specific mortality changes after nephrectomy","volume":"18","author":"Palumbo","year":"2020","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.urolonc.2024.01.004_bib0008","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.eururo.2018.03.011","article-title":"Active Surveillance for localized renal masses: tumor growth, delayed intervention rates, and >5-yr clinical outcomes","volume":"74","author":"McIntosh","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2024.01.004_bib0009","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.euros.2020.11.002","article-title":"Initial observation of a large proportion of patients presenting with clinical stage t1 renal masses: results from the Music-Kidney statewide collaborative","volume":"23","author":"Patel","year":"2021","journal-title":"Eur Urol Open Sci"},{"key":"10.1016\/j.urolonc.2024.01.004_bib0010","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1111\/iju.12527","article-title":"Comorbidities and causes of death in the management of localized T1a kidney cancer","volume":"21","author":"Patel","year":"2014","journal-title":"Int J Urol"},{"key":"10.1016\/j.urolonc.2024.01.004_bib0011","article-title":"Adjusted age-adjusted charlson comorbidity index score as a risk measure of perioperative mortality before cancer surgery","volume":"11","author":"Chang","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.urolonc.2024.01.004_bib0012","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/aje\/kwq433","article-title":"Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries","volume":"173","author":"Quan","year":"2011","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.urolonc.2024.01.004_bib0013","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/j.juro.2012.07.100","article-title":"Competing risks of death in patients with localized renal cell carcinoma: a comorbidity based model","volume":"188","author":"Kutikov","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2024.01.004_bib0014","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00432-019-03042-7","article-title":"The age-adjusted Charlson comorbidity index as a predictor of overall survival of surgically treated non-metastatic clear cell renal cell carcinoma","volume":"146","author":"Kang","year":"2020","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.urolonc.2024.01.004_bib0015","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.juro.2007.10.048","article-title":"Survival analysis of clear cell renal carcinoma according to the Charlson comorbidity index","volume":"179","author":"Santos Arrontes","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2024.01.004_bib0016","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1056\/NEJM197710202971601","article-title":"Multifactorial index of cardiac risk in noncardiac surgical procedures","volume":"297","author":"Goldman","year":"1977","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2024.01.004_bib0017","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.urolonc.2024.01.004_bib0018","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.urolonc.2024.01.004_bib0019","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/ki.2013.444","article-title":"Summary of KDIGO 2012 CKD Guideline: behind the scenes, need for guidance, and a framework for moving forward","volume":"85","author":"Levin","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.urolonc.2024.01.004_bib0020","doi-asserted-by":"crossref","first-page":"79","DOI":"10.14740\/wjon1279","article-title":"Epidemiology of renal cell carcinoma","volume":"11","author":"Padala","year":"2020","journal-title":"World J Oncol"},{"key":"10.1016\/j.urolonc.2024.01.004_bib0021","doi-asserted-by":"crossref","first-page":"18","DOI":"10.7812\/TPP\/18-108","article-title":"Trend of surgical treatment of localized renal cell carcinoma","volume":"23","author":"Jabaji","year":"2019","journal-title":"Perm J"},{"key":"10.1016\/j.urolonc.2024.01.004_bib0022","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.eururo.2021.11.002","article-title":"A clinical decision aid to support personalized treatment selection for patients with clinical t1 renal masses: results from a Multi-institutional competing-risks analysis","volume":"81","author":"Psutka","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2024.01.004_bib0023","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.urology.2023.06.010","article-title":"Building a roadmap for surveillance of renal masses using a modified Delphi method to help achieve consensus","volume":"180","author":"Patel","year":"2023","journal-title":"Urology"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143924000085?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143924000085?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:28:34Z","timestamp":1761042514000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143924000085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S1078143924000085"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2024.01.004","relation":{},"ISSN":["1078-1439"],"issn-type":[{"type":"print","value":"1078-1439"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Simplified cardiovascular index may be the best comorbidity index for clinical use in prediction of mortality for renal cancer patients","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2024.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}